New Onset AF Detected Early by Cardea SOLO™, Facilitating Anticoagulation and Reducing Stroke Risk

ECONOMIC VALUE

Using the Cardea SOLO™ as a tool to support medical necessity to initiate the AF treatment and loop recorder implantation is beneficial for both the patient and the cardiology practice. The patient can receive the treatment they need sooner while reducing potential risk for stroke. The practice can maneuver through medical necessity and gain the ability to perform the interventional medical procedures needed (in this scenario, an implantable loop recorder).

“We really like Cardiac Insight for all the help and support the company offers but most importantly, the Cardea SOLO Sensors are well-designed and the system’s software algorithm is top notch with its arrhythmia analysis and detection. The ability to apply the sensor in the office and be provided an automated report in minimal time has facilitated early stroke intervention and essentially elevated the level of patient care while also expediting our clinical workflow,” said Gary Cox, Cardiology Technician at Advanced Cardiology & Primary Care LLC in Hackettstown, New Jersey. “We no longer have to wait weeks to get a report and feel more comfortable keeping our patient data in-house and avoiding potential data breaches.”

Cardea SOLO’s automated in-office analysis eliminates the need to outsource the processing of the ECG report. Clinicians can generate a report in-office within minutes of the patient returning and interpret the findings. Not having to wait weeks for an independent processing center to provide the ECG report drives clinical efficiency. The Clinician is able to better facilitate patient care and also streamline the practice workflow.